In addition, it has been confirmed that (Wu, 2009) DR5 is generally expressed at extremely higher levels than in normal tissues in a variety of tumor cell types, including breast, endometrial, cervical, ovarian, pancreatic, hepatocellular, and rectal cancers. This evidence concerns the gene TNFRSF10B and neoplasm.